Actively Recruiting

Age: 18Years - 100Years
All Genders
ID05326061

Characterization of Patients at High Risk for the Acquisition of Sexually Transmitted Infection With HIV - a Clinical Study

Led by Medical University of Vienna · Updated on 2022-04-13

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand how new HIV infections occur among people at high risk due to their sexual behaviors. It focuses on individuals who are HIV-negative men who have sex with men (MSM) and transgender people, particularly those who engage in unsafe sex, have recently had a sexually transmitted infection (STI), used post-exposure prophylaxis (PEP), or frequently participate in 'chemsex'. The study is observational and conducted by the Medical University of Vienna to provide insights into HIV transmission and related infections. Participants will be observed over a period of up to 10 years without receiving any treatment as part of the study. Researchers will collect important clinical information related to sexual behaviors, use of HIV pre-exposure prophylaxis, and occurrence of other STIs. Laboratory tests will be performed on blood, urine, and mucosal samples to monitor infections and related health factors. During the study, participants will provide medical history and behavioral information through assessments. Researchers will monitor the incidence of new HIV infections and other sexually transmitted infections throughout the study period. The study involves regular collection of samples and clinical data, with safety and well-being monitored as part of the observational process.

CONDITIONS

Brief Title

Vienna HIV Infection Via Sex Study

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • High risk for acquiring HIV: HIV-negative men who have sex with men (MSM) and transgender individuals who do not consistently use condoms with casual partners or untreated HIV-positive partners, or who recently had an STI, used PEP, or frequently engage in 'chemsex'
  • Age greater than 18 years and less than 100 years
  • Written informed consent for this registry study
Not Eligible

You will not qualify if you...

  • Withdrawal of the written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - Up to 10 years

Participants are observed over time to assess HIV acquisition and incidence of sexually transmitted infections through clinical information and laboratory tests.

Visits scheduled periodically for clinical and laboratory assessments

Trial Site Locations

Total: 1 location

1

Medical University of Vienna

Vienna, Austria, 1090

Actively Recruiting

Loading map...

Research Team

D

David Chromy, MD

A

Armin Rieger, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase 3, Randomized, Active-Controlled, Double-Blind Study...

Human Immunodeficiency Virus (HIV)

Actively Recruiting

81 locations

ACTION HIV: A Global Record of Patients With Anal Squamous C...

Anal Squamous Cell Carcinoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here